Stocks and Investing Stocks and Investing
Tue, December 17, 2024
Mon, December 16, 2024

These stocks made my share portfolio a market-beater in 2024


Published on 2024-12-16 12:41:15 - Motley Fool Australia
  Print publication without navigation

  • Find out what's inside the share portfolio beating the ASX 200 by 52% and the S&P 500 by 36% in 2024. Why it can pay to have high conviction.

The article from Fool.com.au discusses the performance of various stocks that significantly contributed to the author's share portfolio outperforming the market in 2024. Key highlights include the success of Neuren Pharmaceuticals, which saw a 150% increase due to positive developments in its drug pipeline for neurological disorders. RPMGlobal Holdings also performed exceptionally well, with a 100% rise attributed to strong demand for its mining software solutions. Austal benefited from a recovery in the defense sector, leading to a 70% gain. Additionally, Telix Pharmaceuticals surged by 60% following successful trials and regulatory advancements in its cancer diagnostic products. The article also mentions the positive impact of Xero and Altium, which, despite not being the top performers, still contributed to the portfolio's success through steady growth and strategic business moves. The author attributes the portfolio's market-beating performance to a combination of sector-specific growth, innovation, and strategic investments in companies with strong fundamentals.

Read the Full Motley Fool Australia Article at:
[ https://www.fool.com.au/2024/12/17/these-stocks-made-my-share-portfolio-a-market-beater-in-2024/ ]
Contributing Sources